Transforming growth factor β1 directly and reversibly inhibits the initial cell divisions of long-term repopulating hematopoietic stem cells

Blood

Volumn 88, Issue 1, 1996, Pages 82-88

  Sitnicka, Ewa ^b   Ruscetti, Francis W ^b   Priestley, Gregory V ^b   Wolf, Norman S ^b   Bartelmez, Stephen H ^a  

^a SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HOE 33342; INTERLEUKIN 3; INTERLEUKIN 6; RHODAMINE 123; STEM CELL FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CLONING; CELL DIVISION; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO DEVELOPMENT; FEMALE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; MALE; MOUSE; MUSCLE DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL;

EID: 0029948374     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.1.82.bloodjournal88182     Document Type: Article

References (44)

1. Spangrude GJ, Heimfeld S, Weissman IL: Purification and characterization of mouse hematopoietic stem cells. Science 241:58, 1988
2. Spangrude GJ, Scollay R: A simplified method for enrichment of mouse hematopoietic stem cells. Exp Hematol 18:920, 1990
3. Spangrude GJ, Smith L, Uchida N, Ikuta K, Heimfeld S, Frideman J, Weissman IL: Mouse hematopoietic stem cells. Blood 78:1395, 1991
4. Lemischka IR: The hematopoietic stem cell and its clonal progeny: Mechanisms regulating the hierarchy of primitive hematopoietic cells. Cancer Surv 15:3, 1992
5. Vos O, Ploemacher RE: Developments in moderm hematology. Boll Soc Ital Biol Sper 67:435, 1991
6. Uchida N, Aguila HL, Fleming WH, Jerabek L, Wiessman IL: Rapid and sustained hematopoietic recovery in lethally irradiated mice transplanted with purified Thy-1.1 lo Lin-Scal + hematopoietic stem cells. Blood 83:3758, 1994
7. Neben S, Redfearn WJ, Parra M, Brecher G, Pallavicini MG: Short- and long-term repopulation of lethally irradiated mice by bone marrow stem cells enriched on the basis of light scatter and Hoechst 33342 fluorescence. Exp Hematol 19:9, 1991
8. Bartelmez SH, Andrews RG, Berstein ID: Uncovering the heterogeneity of hematopoietic repopulating cells. Exp Hematol 19:861, 1991
9. Jones RJ, Wagner JE, Celano P, Zicha MS, Sharkis SJ: Separation of pluripotent hematopoietic stem cells from spleen colony forming cells. Nature 347:188, 1990
10. Li CL, Johnson GR: Rhodamine 123 reveals heterogeneity within murine Lin-, Sca-1+ hematopoietic stem cells. J Exp Med 175:1443, 1992
11. Wolf NS, Kone A, Priestley GV, Bartelmez SH: In vivo and in vitro characterization of long-term repopulating primitive hematopoietic cells isolated by sequential Hoechst 33342-rhodamine 123 FACS selection. Exp Hematol 21:614, 1993
12. Rizzino A: Transforming growth factor β: Multiple effects on cell differentiation and extracellular matrices. Dev Biol 130:411, 1988
13. Ellingworth LR, Brennan JE, Fok K, Rosen DM, Bentz H, Piez KA, Seyedin SM: Antibodies to the N-terminal portion of cartilage-inducing factor A and transforming growth factor β. Immunochemical localization and association with differentiating cells. J Biol Chem 261:12362, 1986
14. Nemunaitis J, Tompkins CK, Andrews DF, Singer JW: Transforming growth factor β expression in human marrow stromal cells. Eur J Haematol 46:140, 1991
15. 1. Blood 75:96, 1990
16. 1, on lymphopoiesis in long-term bone marrow cultures. Blood 74:1711, 1989
17. Eaves JE, Cashman JD, Kay RJ, Dougherty GJ, Otsuka T, Gaboury LA, Hogge DE, Lansdorp PM, Eaves AC, Humphries RK: Mechanisms that regulate the cell cycle status of the very primitive hematopoietic cells in long-term human marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layer. Blood 78:110, 1991
18. Migdalska A, Molineux G, Demuynck H, Evans GS, Ruscetti FW, Dexter TM: Growth inhibitory effects of transforming growth factor-β1 in vivo. Growth Factors 4:239, 1991
19. Goey H, Keller JR, Back T, Longo DL, Ruscetti FW, Wiltrout RH: Inhibition of early murine hematopoietic progenitor cell proliferation after in vivo locoregional administration of transforming growth factor-β1. J Immunol 143:877, 1989
20. Ruscetti FW, Jacobsen SE, Birchenall-Roberts M, Broxmeyer HE, Engelmann GL, Dubois C, Keller JR: Role of transforming growth factorβ1 in regulation of hematopoiesis. Ann NY Acad Sci 628:31, 1991
21. McNiece IK, Bertoncello I, Keller JR, Ruscetti FW, Hartley CA, Zsebo KM: Transforming growth factor β inhibits the action of stem cell factor on mouse and human hematopoietic progenitors. Int J Cell Cloning 10:80, 1992
22. Keller JR, Bartelmez SH, Sitnicka E, Ruscetti FW, Oriz M, Gooya JM, Jacobsen SEW: Distinct and overlapping effects of macrophage inflammatory protein-1 alpha (MIP-1α) and transforming growth factor-beta (TGF-β) on hematopoietic progenitor/stem cell growth. Blood 84:2175, 1994
23. Ottmann OG, Pelus LM: Differential proliferative effects of transforming growth factor-β on human hematopoietic progenitor cells. J Immunol 140:2661, 1988
24. Keller JR, Jacobsen SE, Sill KT, Ellingsworth LR, Ruscetti FW: Stimulation of granulopoiesis by transforming growth factor β: Synergy with granulocyte/macrophage-colony-stimulating factor. Proc Natl Acad Sci USA 88:7190, 1991
25. Keller JR, McNiece IK, Sill KT, Ellingsworth LR, Quesenberry PJ, Sing GK, Ruscetti FW: Transforming growth factor β directly regulates primitive hematopoietic cell proliferation. Blood 75:596, 1990
26. McAlister I, Wolf NS, Pietrzyk ME, Rabinovitch PS, Priestley GV, Jaeger B: Transplantation of hematopoietic stem cells obtained by a combined dye method fractionation of murine bone marrow. Blood 75:1249, 1990
27. 2 affinity purification. J Immunol 142:1536, 1989
28. Lucas C, Mora-Worms M, Fendly B, Bald L, Figari I, Palladino M: The autocrine production of transforming growth factor β1 during lymphocyte activation: A study with a monoclonal antibody based Elisa. J Immunol 145:1415, 1990
29. Dubois CM, Ruscetti FW, Palaszynski EW, Falk LA, Oppenheim JJ, Keller JR: Transforming growth factor β is a potent inhibitor of interleukin 1 (IL-1) receptor expression: Proposed mechanism of inhibition of IL-1 action. J Exp Med 172:737, 1990
30. Jacobsen SEW, Ruscetti FW, Dubois CM, Lee J, Boone TC, Keller JR: Transforming growth factor-β trans-modulate the expression of colony stimulating factor receptors on murine hematopoietic progenitor cell lines. Blood 77:1706, 1991
31. Dubois CM, Ruscetti FW, Stankova J, Keller JR: Transforming growth factor-β regulates c-kit message stability and cell-surface expression in hematopoietic progenitors. Blood 83:3138, 1994
32. de Vos S, Brach MA, Asano Y, Wolf-Dieter L, Bettelheim P, Grass H-J, Herrmann F: Transforming growth factor-β1 interfers with the proliferation-inducing activity of stem cell factor in myelogenous leukemia blasts through functional down-regulation of the c-kit proto-oncogene product. Cancer Res 53:3638, 1993
33. 1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domain. Cell 62:777, 1990
34. Laiho M, DeCaprio JA, Ludlow JW, Livingston DM, Massague J: Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell 62:175, 1990
35. Polyak K, Kato J, Solomon MJ, Sherr CJ, Massague J, Roberts JM, Koff A: p27Kip1, A cyclin-Cdk inhibitor, links transforming factor β and contact inhibition to cell cycle arrest. Genes Dev 8:9, 1994
36. 1. Science 260:536, 1993
37. 1 inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell 74:1009, 1993
38. Datto MB, Li Y, Panus JF, Howe DJ, Xiong Y, Wang XF: Transforming growth factor β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc Natl Acad Sci USA 92:5545, 1995
39. 1-induced cell cycle arrest. Nature 371:257, 1994
40. Chantry D, Turner M, Abney E, Feldmann M: Modulation of cytokine production by transforming growth factor β. J Immunol 142:4295, 1989
41. Heinrich MC, Dooley DC, Koeble WW: Transforming growth factor β1 inhibits expression of the gene products for steel factor and its receptor (c-kit). Blood 85:1769, 1995
42. Espevik T, Figari IS, Shalby MR, Lackides GA, Lewis GD, Shepard HM, Palladino MA Jr: Inhibition of cytokine production by cyclosporin A and transforming growth factor β. J Exp Med 166:571, 1987
43. Hatzfeld J, Li M-L, Brown EL, Sookedo H, Levesque J-P, O'Toole T, Gurney C, Clark SC, Hatzfeld A: Release of early human hematopoietic progenitors from quiescence by antisence transforming factor β1 or Rb oligonucleotides. J Exp Med 174:925, 1991
44. Howe PH, Draetta G, Leof EB: Transforming growth factor β1 inhibition of p34cedc2 phosphorylation and histone H1 kinase activity is associated with G1/S-phase growth arrest. Mol Cell Biol 11:1185, 1991